Financial
FY2025 revenue CHF 292.1m (+1.9%); operating margin 6.9%; net income CHF 15.1m.
No debt; CHF 29.6m cash.
HQ Switzerland · Europe
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
FY2025 revenue CHF 292.1m (+1.9%); operating margin 6.9%; net income CHF 15.1m.
No debt; CHF 29.6m cash.
Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
| Year | Revenue | Growth | Operating profit | Net income | Covers |
|---|---|---|---|---|---|
| FY2025 | CHF 292.1m | +1.9% | CHF 20.3m | CHF 15.1m | Ascom |
Products not yet catalogued.
FY2025 revenue CHF 292.1m (+1.9%); operating margin 6.9%; net income CHF 15.1m.
No debt; CHF 29.6m cash.
Sep 2025: CEO Nicolas Vanden Abeele left Ascom after almost four years, with board member Michael Reitermann as interim CEO; Ascom named David Hale as its new CEO in Dec 2025.
Mar 2025: a cyber attack compromised Ascom's technical ticketing system, with the Hellcat ransomware group claiming responsibility. Ascom said other IT and customer systems were unaffected and business was operating normally. NHS DSPT status not yet checked.
No recalls, safety notices or clinical safety actions involving Ascom's nurse call or clinical communications products found in HSH's search of the last 24 months.
Sep 2026: Ascom won one of two framework agreements with Norway's Helse Sør-Øst, estimated at CHF 80m over seven years. Dec 2025: Ascom announced a partnership to supply smart nurse call to the NHS National Rehabilitation Centre run by Nottingham University Hospitals.
No competitors linked yet.